Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Noninvasive Cancer Diagnostics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Noninvasive Cancer Diagnosticsmarket, defines the market attractiveness level of Noninvasive Cancer Diagnostics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Noninvasive Cancer Diagnostics industry, describes the types of Noninvasive Cancer Diagnostics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Noninvasive Cancer Diagnostics market and the development prospects and opportunities of Noninvasive Cancer Diagnostics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Noninvasive Cancer Diagnostics market in Chapter 13.
By Player:
AandG Pharmaceutical, Inc (US)
IVDiagnostics, Inc (US)
AVIVA Biosciences Corporation (US)
Gen-Probe Incorporated (US)
Laboratory Corporation of America Holdings (LabCorp) (US)
BIOVIEW Inc (US)
Digene Corporation (US)
Affymetrix Inc (US)
Quest Diagnostics Incorporated Cancer Genetics Inc (US)
Precision Therapeutics, Inc (US)
By Type:
Clinical Chemistry
Immunochemistry/Immunoassay
Molecular Diagnostics
Others
By End-User:
Solid Tumors
Blood Cancer
Lung Cancer
Breast Cancer
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Noninvasive Cancer Diagnostics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Noninvasive Cancer Diagnostics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Noninvasive Cancer Diagnostics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Noninvasive Cancer Diagnostics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Noninvasive Cancer Diagnostics Market Analysis and Outlook to 2022
-
7.1 Global Noninvasive Cancer Diagnostics Consumption (2017-2022)
-
7.2 United States Noninvasive Cancer Diagnostics Consumption (2017-2022)
-
7.3 Europe Noninvasive Cancer Diagnostics Consumption (2017-2022)
-
7.4 China Noninvasive Cancer Diagnostics Consumption (2017-2022)
-
7.5 Japan Noninvasive Cancer Diagnostics Consumption (2017-2022)
-
7.6 India Noninvasive Cancer Diagnostics Consumption (2017-2022)
-
7.7 South Korea Noninvasive Cancer Diagnostics Consumption (2017-2022)
8 Region and Country-wise Noninvasive Cancer Diagnostics Market Analysis and Outlook to 2028
-
8.1 Global Noninvasive Cancer Diagnostics Consumption Forecast (2022-2028)
-
8.2 United States Noninvasive Cancer Diagnostics Consumption Forecast (2022-2028)
-
8.3 Europe Noninvasive Cancer Diagnostics Consumption Forecast (2022-2028)
-
8.4 China Noninvasive Cancer Diagnostics Consumption Forecast (2022-2028)
-
8.5 Japan Noninvasive Cancer Diagnostics Consumption Forecast (2022-2028)
-
8.6 India Noninvasive Cancer Diagnostics Consumption Forecast (2022-2028)
-
8.7 South Korea Noninvasive Cancer Diagnostics Consumption Forecast (2022-2028)
9 Global Noninvasive Cancer Diagnostics Market Outlook by Types and Applications to 2022
-
9.1 Global Noninvasive Cancer Diagnostics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Clinical Chemistry Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Immunochemistry/Immunoassay Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Noninvasive Cancer Diagnostics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Solid Tumors Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
9.2.5 Global Others Consumption and Growth Rate (2017-2022)
10 Global Noninvasive Cancer Diagnostics Market Outlook by Types and Applications to 2028
-
10.1 Global Noninvasive Cancer Diagnostics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Clinical Chemistry Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Immunochemistry/Immunoassay Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Noninvasive Cancer Diagnostics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Solid Tumors Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Noninvasive Cancer Diagnostics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Noninvasive Cancer Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Noninvasive Cancer Diagnostics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Noninvasive Cancer Diagnostics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Noninvasive Cancer Diagnostics Market Competitive Analysis
-
14.1 AandG Pharmaceutical, Inc (US)
-
14.1.1 AandG Pharmaceutical, Inc (US) Company Details
-
14.1.2 AandG Pharmaceutical, Inc (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 AandG Pharmaceutical, Inc (US) Noninvasive Cancer Diagnostics Product and Service
-
14.2 IVDiagnostics, Inc (US)
-
14.2.1 IVDiagnostics, Inc (US) Company Details
-
14.2.2 IVDiagnostics, Inc (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 IVDiagnostics, Inc (US) Noninvasive Cancer Diagnostics Product and Service
-
14.3 AVIVA Biosciences Corporation (US)
-
14.3.1 AVIVA Biosciences Corporation (US) Company Details
-
14.3.2 AVIVA Biosciences Corporation (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 AVIVA Biosciences Corporation (US) Noninvasive Cancer Diagnostics Product and Service
-
14.4 Gen-Probe Incorporated (US)
-
14.4.1 Gen-Probe Incorporated (US) Company Details
-
14.4.2 Gen-Probe Incorporated (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Gen-Probe Incorporated (US) Noninvasive Cancer Diagnostics Product and Service
-
14.5 Laboratory Corporation of America Holdings (LabCorp) (US)
-
14.5.1 Laboratory Corporation of America Holdings (LabCorp) (US) Company Details
-
14.5.2 Laboratory Corporation of America Holdings (LabCorp) (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Laboratory Corporation of America Holdings (LabCorp) (US) Noninvasive Cancer Diagnostics Product and Service
-
14.6 BIOVIEW Inc (US)
-
14.6.1 BIOVIEW Inc (US) Company Details
-
14.6.2 BIOVIEW Inc (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 BIOVIEW Inc (US) Noninvasive Cancer Diagnostics Product and Service
-
14.7 Digene Corporation (US)
-
14.7.1 Digene Corporation (US) Company Details
-
14.7.2 Digene Corporation (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Digene Corporation (US) Noninvasive Cancer Diagnostics Product and Service
-
14.8 Affymetrix Inc (US)
-
14.8.1 Affymetrix Inc (US) Company Details
-
14.8.2 Affymetrix Inc (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Affymetrix Inc (US) Noninvasive Cancer Diagnostics Product and Service
-
14.9 Quest Diagnostics Incorporated Cancer Genetics Inc (US)
-
14.9.1 Quest Diagnostics Incorporated Cancer Genetics Inc (US) Company Details
-
14.9.2 Quest Diagnostics Incorporated Cancer Genetics Inc (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Quest Diagnostics Incorporated Cancer Genetics Inc (US) Noninvasive Cancer Diagnostics Product and Service
-
14.10 Precision Therapeutics, Inc (US)
-
14.10.1 Precision Therapeutics, Inc (US) Company Details
-
14.10.2 Precision Therapeutics, Inc (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Precision Therapeutics, Inc (US) Noninvasive Cancer Diagnostics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Noninvasive Cancer Diagnostics
-
Figure Noninvasive Cancer Diagnostics Picture
-
Table Global Noninvasive Cancer Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Noninvasive Cancer Diagnostics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Noninvasive Cancer Diagnostics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Noninvasive Cancer Diagnostics Consumption by Country (2017-2022)
-
Figure United States Noninvasive Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Table Europe Noninvasive Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure China Noninvasive Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Japan Noninvasive Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure India Noninvasive Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Noninvasive Cancer Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global Noninvasive Cancer Diagnostics Consumption Forecast by Country (2022-2028)
-
Figure United States Noninvasive Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Noninvasive Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Noninvasive Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Noninvasive Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Noninvasive Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Noninvasive Cancer Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinical Chemistry Consumption and Growth Rate (2017-2022)
-
Figure Global Immunochemistry/Immunoassay Consumption and Growth Rate (2017-2022)
-
Figure Global Molecular Diagnostics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Solid Tumors Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Lung Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Breast Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Clinical Chemistry Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunochemistry/Immunoassay Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Molecular Diagnostics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Solid Tumors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Lung Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Breast Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Noninvasive Cancer Diagnostics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Noninvasive Cancer Diagnostics Export by Region (Top 5 Countries) (2017-2028)
-
Table AandG Pharmaceutical, Inc (US) (Foundation Year, Company Profile and etc.)
-
Table AandG Pharmaceutical, Inc (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AandG Pharmaceutical, Inc (US) Noninvasive Cancer Diagnostics Product and Service
-
Table IVDiagnostics, Inc (US) (Foundation Year, Company Profile and etc.)
-
Table IVDiagnostics, Inc (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table IVDiagnostics, Inc (US) Noninvasive Cancer Diagnostics Product and Service
-
Table AVIVA Biosciences Corporation (US) (Foundation Year, Company Profile and etc.)
-
Table AVIVA Biosciences Corporation (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AVIVA Biosciences Corporation (US) Noninvasive Cancer Diagnostics Product and Service
-
Table Gen-Probe Incorporated (US) (Foundation Year, Company Profile and etc.)
-
Table Gen-Probe Incorporated (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Gen-Probe Incorporated (US) Noninvasive Cancer Diagnostics Product and Service
-
Table Laboratory Corporation of America Holdings (LabCorp) (US) (Foundation Year, Company Profile and etc.)
-
Table Laboratory Corporation of America Holdings (LabCorp) (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Laboratory Corporation of America Holdings (LabCorp) (US) Noninvasive Cancer Diagnostics Product and Service
-
Table BIOVIEW Inc (US) (Foundation Year, Company Profile and etc.)
-
Table BIOVIEW Inc (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table BIOVIEW Inc (US) Noninvasive Cancer Diagnostics Product and Service
-
Table Digene Corporation (US) (Foundation Year, Company Profile and etc.)
-
Table Digene Corporation (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Digene Corporation (US) Noninvasive Cancer Diagnostics Product and Service
-
Table Affymetrix Inc (US) (Foundation Year, Company Profile and etc.)
-
Table Affymetrix Inc (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Affymetrix Inc (US) Noninvasive Cancer Diagnostics Product and Service
-
Table Quest Diagnostics Incorporated Cancer Genetics Inc (US) (Foundation Year, Company Profile and etc.)
-
Table Quest Diagnostics Incorporated Cancer Genetics Inc (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Quest Diagnostics Incorporated Cancer Genetics Inc (US) Noninvasive Cancer Diagnostics Product and Service
-
Table Precision Therapeutics, Inc (US) (Foundation Year, Company Profile and etc.)
-
Table Precision Therapeutics, Inc (US) Noninvasive Cancer Diagnostics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Precision Therapeutics, Inc (US) Noninvasive Cancer Diagnostics Product and Service
-
